Rosen, top-ranked investor counsel, encourages bolt biotherapeutics, inc. investors to secure counsel before important deadline in securities class action – bolt

New york, aug. 14, 2024 (globe newswire) -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of bolt biotherapeutics, inc. (nasdaq: bolt) between february 5, 2021 and may 14, 2024, both dates inclusive (the “class period”), of the important september 3, 2024 lead plaintiff deadline.
TOP Ratings Summary
TOP Quant Ranking